Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Psivant Therapeutics has raised $47.5M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Psivant Therapeutics's investors include Samsara BioCapital, Roivant Sciences, Lightstone Ventures, Eurofarma, YK Bioventures.
Psivant Therapeutics is headquartered in Watertown, United States.
Psivant Therapeutics is a biotechnology company that offers drug design, biology research, and development services.
Psivant Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Psivant Therapeutics — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/psivant-therapeutics. Accessed November 12, 2026.
VCBacked. (2025). Psivant Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/psivant-therapeutics
{{cite web |title=Psivant Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/psivant-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Psivant Therapeutics? Request a listing update